Ghost Tree Capital’s Immunomedics Inc IMMU Stock Holding History

Ghost Tree Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,201,000	Closed	-$15.9M	–	67
2019 Q3	$15.9M	Buy	1,201,000 +401,000	+50%	+$5.89M	4.06%	6
2019 Q2	$11.1M	Buy	+800,000	New	+$12M	2.3%	12
2018 Q1	–	Sell	-1,300,000	Closed	-$21M	–	69
2017 Q4	$21M	Buy	+1,300,000	New	+$15.3M	4.93%	3
2016 Q3	–	Sell	-200,000	Closed	-$464K	–	105
2016 Q2	$464K	Buy	+200,000	New	+$668K	0.13%	58

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Ghost Tree Capital's IMMU Position: Q3 2020 in Review

Ghost Tree Capital sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 575,000 shares — an estimated $20.4M sold.

Ghost Tree Capital first reported a position in IMMU in Q2 2016 and held it in 17 quarters. The position peaked at $29.6M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

Ghost Tree Capital reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
Ghost Tree Capital sold 575,000 Immunomedics Inc shares in Q3 2020, an estimated $20.4M.
Ghost Tree Capital first reported a position in Immunomedics Inc in Q2 2016 and held it in 17 quarters.
Ghost Tree Capital's Immunomedics Inc position peaked at $29.6M in Q2 2018.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Ghost Tree Capital's 13F filing for Q3 2020, filed 16 Nov 2020.